Compare Niramas Utama Tbk. (JELI) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Niramas Utama Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Niramas Utama Tbk. trades at Rp635 (market cap 848.22B, 10.75M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp242 (market cap 164.65B, 187.4K 24h volume). The key difference: Niramas Utama Tbk. is far larger — about 5.2× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Niramas Utama Tbk. is more actively traded (10.75M versus 187.4K). Which is the better fit depends on your goals.
| JELI | OBAT | |
|---|---|---|
Market Cap | 848.22B | 164.65B |
Volume | 10.75M | 187.4K |
Lot | 107.48K | 1.87K |
Turnover | 6.9B | 44.35M |
Average Price | 642.24 | 236.67 |
Value | 6.9B | 44.35M |
Indicative Equilibrium Price | 635 | 242 |
Indicative Equilibrium Volume | 6.4K | 500 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Niramas Utama Tbk.
PT. Niramas Utama Tbk. (the Company) formerly PT Nata Sari Raya was established based on Notarial Deed No. 86 dated 22 November 1990, by Notary Samsul Hadi, S.H. The Company started its commercial operations in 1994. The parent entity and the ultimate parent entity of the Company are PT Niramas Utama International and PT Supra Sentral Investama
Read more on JELI →About Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →
